companydata.dkcompanydata.dk

CRSG Denmark ApS: Financial statements 2022

CVR: 37084964

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

CRSG Denmark ApS (CVR 37084964) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -485,263 and a net result of DKK -7,274,589 compared with DKK -8,875,138 the year before. Equity in the 2022 report amounted to DKK 95,829,231. The solvency ratio was 71.6%.

Gross Profit
DKK -485,263
Profit/Loss
DKK -7,274,589
Equity
DKK 95,829,231
Total Assets
DKK 133,802,420
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--485 t.-7.3 mio.95.8 mio.0
2021--1.6 mio.-8.9 mio.14.3 mio.2
2020--609 t.-17.4 mio.-3.2 mio.2
2019--757 t.-10.3 mio.14.2 mio.2
2018--1.7 mio.-16.6 mio.24.5 mio.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on CRSG Denmark ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

CRSG Denmark ApS: The 2021 annual report is outJul 20, 2022

CRSG Denmark ApS has published its annual report for 2021. Gross profit came to DKK -1,630,854, and the net result was DKK -8,875,138.

About CRSG Denmark ApS

CRSG Denmark ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2015. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named KR 1813 ApS. The management consists of Pernille Schlütter Beck. The board consists of Daniel Fehr (chair), Mathias Riis Damgaard, Pernille Schlütter Beck and Raoul Francis Dias. The company is owned by COLOSSEUMKLINIKKEN DANMARK ApS. The company has 1 employee (2022). In 2025, the company reported a net result of DKK 27,089,882 compared with DKK -2,316,369 the year before. Equity in the 2025 report amounted to DKK 104,915,276.

Source: annual report 2025, Danish Business Authority